Watson Challenges Cancer

The IBM supercomputer, famous for its game show performance, will aid in cloud-based analyses of genomic data.  

kerry grens
Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at...

View full profile.


Learn about our editorial policies.

Mar 20, 2014

WIKIMEDIA, CLOCKREADYIBM’s Watson, a supercomputer and one of the most famous “Jeopardy!” champions, will now be deployed in the service of oncologists. The New York Genome Center and IBM this week (March 19) announced a partnership through which Watson will analyze genomic data, with the goal of developing personalized medicine for cancer patients.

“We’re hoping Watson’s learning model can find associations faster than we can and they’ll be able to tune the sets of drugs to at least prioritize and give doctors the ability to drill down so that they can make better determinations of what to try,” Toby Bloom, the deputy scientific director for informatics at the New York Genome Center, told Forbes.

At the outset, Watson will compare genomic data from tumors and non-tumorous tissue from a small group of patients with glioblastoma, a notoriously difficult-to-treat brain cancer. “Time definitely is not on your side...

According to Forbes, if the initial glioblastoma project is a success, the effort will be scaled up to include more patients.

Interested in reading more?

Watson Challenges Cancer

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?